The invention relates to the use of erythropoietin (EPO), particularly EPO in a pharmaceutical preparation on a polymer basis that stabilizes the active substance for the treatment of traumatized skin, particularly for wound healing with mechanical or pathological injuries or with burns. The invention particularly also relates to special viscous or gel-like formulations, particularly on the basis of polysaccharides, preferably cellulose derivatives, which comprise EPO and can stabilize it and can slowly and steadily deliver it to the wound.
